Financhill
Sell
32

PDSB Quote, Financials, Valuation and Earnings

Last price:
$1.01
Seasonality move :
24.68%
Day range:
$0.91 - $1.03
52-week range:
$0.85 - $4.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.46x
Volume:
137.9K
Avg. volume:
643.9K
1-year change:
-69.44%
Market cap:
$46.8M
Revenue:
--
EPS (TTM):
-$1.17

Earnings Data

Next earnings date for PDSB
May 15
2025
Most recent earnings per share
-$0.21
Beat by $0.07
(Mar 27/2025)
Consensus Estimate
-$0.28
(Mar 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PDSB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 -- -- -- -$0.23 --
05/15/2025 Q1 -- -- -- -$0.22 --
03/27/2025 Q4 -- -- -$0.21 -$0.28 $0.07
11/14/2024 Q3 -- -- -$0.29 -$0.28 -$0.01
08/13/2024 Q2 -- -- -$0.23 -$0.33 $0.10
05/15/2024 Q1 -- -- -$0.30 -$0.36 $0.06
03/27/2024 Q4 -- -- -$0.35 -$0.42 $0.07
11/14/2023 Q3 -- -- -$0.35 -$0.47 $0.12
08/14/2023 Q2 -- -- -$0.37 -$0.34 -$0.03
05/15/2023 Q1 -- -- -$0.32 -$0.30 -$0.02
03/28/2023 Q4 -- -- -$0.67 -$0.30 -$0.37
11/14/2022 Q3 -- -- -$0.26 -$0.28 $0.02
08/08/2022 Q2 -- -- -$0.20 -$0.28 $0.08
05/11/2022 Q1 -- -- -$0.32 -$0.22 -$0.10
03/31/2022 Q4 -- -- -$0.23 -$0.25 $0.02
11/10/2021 Q3 -- -- -$0.24 -$0.20 -$0.04
08/12/2021 Q2 -- -- -$0.03 -$0.16 $0.13
05/13/2021 Q1 -- -- -$0.14 -$0.17 $0.03
03/18/2021 Q4 -- -- -$0.16 -$0.19 $0.03
11/02/2020 Q3 -- -- -$0.21 -$0.14 -$0.07
08/13/2020 Q2 -- -- -$0.19 -$0.23 $0.04
05/13/2020 Q1 -- -- -$0.39 -$0.15 -$0.24
02/21/2020 Q4 -- -- -$0.84 -$1.00 $0.16
09/30/2019 Q3 -- -- -$1.10 -$0.82 -$0.28
08/01/2018 Q2 -- -- -$0.19 -$0.53 $0.34
05/01/2018 Q1 -- -- -$0.58 -$0.53 -$0.05
03/01/2018 Q4 -- -- -$0.45 -$0.43 -$0.02
11/01/2017 Q3 -- -- -$0.37 -$0.48 $0.11
08/01/2017 Q2 -- -- -$0.44 -$0.44 $0.00
05/03/2017 Q1 -- -- -$0.42 -$0.42 $0.00
03/02/2017 Q4 -- -- -$0.33 -$0.41 $0.08
11/01/2016 Q3 -- -- -$0.37 -$0.40 $0.03

PDS Biotechnology Earnings Questions

  • How Much did PDS Biotechnology Generate in Revenue Last Quarter?

    PDS Biotechnology reported -- worth of top line sales in its most recent quarter.

  • Did PDS Biotechnology Beat Earnings Last Quarter?

    PDS Biotechnology announced earnings per share of -$0.21 which represents a beat of analyst forecast a -$0.28 per share.

  • Is PDS Biotechnology Profitable?

    PDS Biotechnology reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for PDS Biotechnology EPS Next Year?

    PDS Biotechnology's earnings are forecast to decrease from -$1.03 per share to -$0.95 per share next year representing a decrease of -7.77%.

  • When is PDS Biotechnology's Earnings Date?

    PDS Biotechnology's next earnings date is May 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will NVIDIA Return to Its 52-Week High?
Will NVIDIA Return to Its 52-Week High?

NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…

Will JP Morgan’s AI Advisor Be a Winner?
Will JP Morgan’s AI Advisor Be a Winner?

JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…

Is Revolve Group Stock a Buy, Sell or Hold?
Is Revolve Group Stock a Buy, Sell or Hold?

Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…

Stock Ideas

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Sell
50
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Buy
52
RGC alert for Apr 12

Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.

Buy
52
SLP alert for Apr 12

Simulations Plus [SLP] is up 26.73% over the past day.

Buy
89
GDXU alert for Apr 12

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock